All Type of News
KPMA’s emergency committee striving to publicize contributing roles of local pharmaceutical firms
The pharmaceutical industry has never really had a good reputation, either here or elsewhere. Behind the life-curing business are heavy lobbying, dirty politics and giant rebates for favorite buyers, all of which is r...
Notice for bioequivalence testing of combination products to be made public in November
The Notice designed to redefine the bioequivalence testing of combined preparations is likely to be delayed due to screening of the Office of Prime Minister and final confirmation of the commissioner of the Korea Food...
Aclasta patients get more insurance coverage
Novartis Korea said on March 11 that health insurance coverage for Aclasta (zoledronate 5 mg) has been expanded in patients (aged over 65 years) with previous hip and vertebral fracture.
Zoledronate has been approv...
Establishment of new body to promote development of small wholesalers eyed
Influenced by the rapidly changing pharmaceutical environments, a new organization designed to promote mutual benefits of small- and medium-sized wholesalers will be set up, according to pharmaceutical business source...
Oscotec wins Europe patent for BT-201 for treatment of arthritis
Oscotec Inc., a local bone-related biopharmaceutical company, said on March 10 that it has recently won a patent of its anti-arthritis drug, BT-201, from the European Patent Office for the treatment of arthritis
Th...
Kyungdong Pharm’s Ryu to head KPMA emergency committee
The Korea Pharmaceutical Manufacturers Association announced on March 11 it has unanimously elected Ryu Duck-hee as a head of the association’s newly established emergency committee after ex-president Auh June-sun res...
Medium-sized drugmakers hit by poor sales and net profit last year
Overall, medium-sized pharmaceutical firms ranging from 50 to 200 billion in sales suffered from poor revenues and/or earnings last year due chiefly to the government’s anti-rebate measures, according to Yakup Shinmoo...
More strict production hygiene standards eyed
Buildings and facilities used in the manufacture of cephalosporins and cytotoxic agents should be separated from other production areas to minimize potential contamination, according to the Korea Food and Drug Adminis...
New body set to help beleaguered pharmaceutical firms
The Korea Drug Research Association (KDRA) said it will establish a special unit of 50 experts from seven subcommittees, such as industry nurturing strategy, research and development, global standards, marketing and i...
First PEET due August 21
The first-year Pharmacy Education Eligibility Test (PEET) will be held on August 21, according to a timetable announced by the Korea Pharmacy College Education Committee on March 10.
The LEET is an exam for applica...
